Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity-matched retrospective cohort study of a pan-provincial program in Alberta, Canada

Objectives: Post-marketing surveillance of sotrovimab's effect during implementation in the Canadian population is limited. Methods: The study used a propensity score–matched retrospective cohort design. Follow-up began between the periods of December 15, 2021 and April 30 2022. The study assessed a...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Gregory Farmer, Khokan C. Sikdar, TKT Lo, John Conly, Jeremy Slobodan, Jordan Ross, Samantha James, Hussain Usman, Kyle Kemp, Kristi Baker, Karen Doucette, Cheri Nijssen-Jordan, Lynora M. Saxinger, A. Mark Joffe
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-09-01
Serie:	International Journal of Infectious Diseases
Soggetti:	Sotrovimab COVID-19 Retrospective Severe outcomes 30-day mortality
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1201971224002078
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!